SSII

SS Innovations International Inc. Common Stock

SSII
Closed
$3.62
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 483 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.
Country

US

CEO

Dr. Sudhir Srivastava

IPO date

2018

Employees

483

ISIN

US05453U2033

Key stats

Open

$3.58

Volume

31.70K

Market cap

$726.48M

Prev. close

$3.58

Impl / hst vl

-

Open interest

$0.00

$3.51

Day’s Range

$3.77

$3.11

52W Range

$6.05

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
14.99
P/B
13.32
Current ratio
2.54
Debt / Equity
-0.09
ROE
-23.00%
Gross margin
47.99%
Income growth
44.96%
FCF growth
-26.84

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.14
The top 3 analysts forecasts that 12-month price may increase by 97.24%, with a low of $7.07 and a high of $7.35
$7.07
Low
$7.14
Avg
$7.35
High
Current price

Earnings

Q1 ‘26 revenue
$11.10M
Q1 ‘26 net income
-$3.58M
Revenue
Net income
Previous EPS
-
Estimate EPS
-$0.01
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply